Skip to main content
Top
Published in: Irish Journal of Medical Science (1971 -) 4/2015

01-12-2015 | Original Article

Long-term follow-up of women with breast cancer: rationale for policy change

Authors: T. McCarthy, L. Mullen, H. Murphy, D. Carey, M. Laffoy

Published in: Irish Journal of Medical Science (1971 -) | Issue 4/2015

Login to get access

Abstract

Background

The number of breast cancer survivors in our ageing population continues to rise. Policy makers internationally are seeking to identify alternatives to follow-up care in an acute setting.

Aims

The National Cancer Control Programme set out to develop a new policy for long-term follow-up of breast cancer survivors in Ireland.

Methods

Policy development was informed by analysis of current attendances at breast surgical clinics for routine follow-up, extraction of the necessary components of follow-up from international guidelines and focus group research with Irish patients.

Results

Intensive follow-up investigations, other than mammography, do not confer additional survival benefit or improved quality of life. Provision of routine follow-up care of breast cancer survivors by GPs has been shown to be equivalent to follow-up by specialist clinics, in terms of clinical outcomes, patient quality of life and patient satisfaction. In Ireland, routine follow-up accounted for 15.4 % (95 % CI: 13.8–17.0 %) of clinic appointments. A third were at least 5 years post-operative. Women highlighted issues such as attachment to specialist services, importance of communication and need for clarity as to where responsibility of care lies. Reassurance, confidence in the primary care practitioner, and coordination of multiple appointments were also identified as important issues.

Conclusion

A significant proportion of breast cancer survivors attending hospital surgical clinics for long-term follow-up could be safely discharged at 5 years, with the hospital maintaining responsibility for annual mammography. Successful implementation will depend on informed patients, clinicians’ acceptance and communication between primary and secondary care.
Literature
1.
go back to reference Department of Health and Children (2006) A strategy for cancer control in Ireland. The Stationery Office, Dublin Department of Health and Children (2006) A strategy for cancer control in Ireland. The Stationery Office, Dublin
2.
go back to reference Health Information and Quality Authority (2006) National quality assurance standards for symptomatic breast disease services. Developing quality care for breast services in Ireland. HIQA, Dublin Health Information and Quality Authority (2006) National quality assurance standards for symptomatic breast disease services. Developing quality care for breast services in Ireland. HIQA, Dublin
3.
go back to reference National Cancer Registry of Ireland (2013) Cancer in Ireland—annual report of the national cancer registry. NCRI, Cork National Cancer Registry of Ireland (2013) Cancer in Ireland—annual report of the national cancer registry. NCRI, Cork
4.
go back to reference Cameron D (2008) Extended follow-up of breast cancer patients in clinic wastes time for both patients and doctors: the case against. Breast Cancer Res 10(4):S8PubMedCentralCrossRefPubMed Cameron D (2008) Extended follow-up of breast cancer patients in clinic wastes time for both patients and doctors: the case against. Breast Cancer Res 10(4):S8PubMedCentralCrossRefPubMed
5.
go back to reference Khatcheressian JL, Wolff AC, Smith TJ et al (2006) American society of clinical oncology. Update of the breast cancer follow-up and management guidelines in the adjuvant setting. J Clin Oncol 24(31):5091–5097CrossRefPubMed Khatcheressian JL, Wolff AC, Smith TJ et al (2006) American society of clinical oncology. Update of the breast cancer follow-up and management guidelines in the adjuvant setting. J Clin Oncol 24(31):5091–5097CrossRefPubMed
6.
go back to reference Kataja V, Castiglione M (2009) Primary breast cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol 20(S4):10–14PubMed Kataja V, Castiglione M (2009) Primary breast cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol 20(S4):10–14PubMed
7.
go back to reference National Comprehensive Cancer Network (2010) NCCN clinical practice guidelines in oncology—guidelines for the surveillance of breast cancer (V2) National Comprehensive Cancer Network (2010) NCCN clinical practice guidelines in oncology—guidelines for the surveillance of breast cancer (V2)
8.
go back to reference Montgomery DA, Krupa K, Cooke TG (2009) Locoregional relapse after breast cancer: most relapses occur late and are not clinically detected. Breast J 15(2):163–167CrossRefPubMed Montgomery DA, Krupa K, Cooke TG (2009) Locoregional relapse after breast cancer: most relapses occur late and are not clinically detected. Breast J 15(2):163–167CrossRefPubMed
9.
go back to reference Grunfeld E, Levine MN, Julian JA et al (2006) Randomized trial of long-term follow-up for early-stage breast cancer: a comparison of family physician versus specialist care. J Clin Oncol 24(6):848–855CrossRefPubMed Grunfeld E, Levine MN, Julian JA et al (2006) Randomized trial of long-term follow-up for early-stage breast cancer: a comparison of family physician versus specialist care. J Clin Oncol 24(6):848–855CrossRefPubMed
10.
go back to reference Rojas MP, Telaro E, Russo A et al (2005) Follow-up strategies for women treated for early breast cancer. Cochrane Database Syst Rev 1(1):CD001768PubMed Rojas MP, Telaro E, Russo A et al (2005) Follow-up strategies for women treated for early breast cancer. Cochrane Database Syst Rev 1(1):CD001768PubMed
11.
go back to reference Liberati A (1995) The GIVIO trial on the impact of follow-up care on survival and quality of life in breast cancer patients. Ann Oncol 6(S2):S41–S46CrossRef Liberati A (1995) The GIVIO trial on the impact of follow-up care on survival and quality of life in breast cancer patients. Ann Oncol 6(S2):S41–S46CrossRef
12.
go back to reference Grunfeld E, Dhesy-Thind S, Levine M, Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer (2005) Clinical practice guidelines for the care and treatment of breast cancer: follow-up after treatment for breast cancer (summary of the 2005 update). CMAJ 172:1319–1320PubMedCentralCrossRefPubMed Grunfeld E, Dhesy-Thind S, Levine M, Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer (2005) Clinical practice guidelines for the care and treatment of breast cancer: follow-up after treatment for breast cancer (summary of the 2005 update). CMAJ 172:1319–1320PubMedCentralCrossRefPubMed
13.
go back to reference National Institute for Clinical Excellence (2009) Early and locally advanced breast cancer: diagnosis and treatment, NICE guidelines [CG80] National Institute for Clinical Excellence (2009) Early and locally advanced breast cancer: diagnosis and treatment, NICE guidelines [CG80]
14.
go back to reference Beaver K, Tysver-Robinson D, Campbell M et al (2009) Comparing hospital and telephone follow-up after treatment for breast cancer: randomised equivalence trial. BMJ 338:314–317CrossRef Beaver K, Tysver-Robinson D, Campbell M et al (2009) Comparing hospital and telephone follow-up after treatment for breast cancer: randomised equivalence trial. BMJ 338:314–317CrossRef
15.
go back to reference Lewis R, Neal RD, Williams NH et al (2009) Nurse-led vs. conventional physician-led follow-up for patients with cancer: systematic review. J Adv Nurs 65(4):706–723CrossRefPubMed Lewis R, Neal RD, Williams NH et al (2009) Nurse-led vs. conventional physician-led follow-up for patients with cancer: systematic review. J Adv Nurs 65(4):706–723CrossRefPubMed
16.
go back to reference Brown L, Payne S, Royle G (2002) Patient initiated follow up of breast cancer. Psychooncology 11(4):346–355CrossRefPubMed Brown L, Payne S, Royle G (2002) Patient initiated follow up of breast cancer. Psychooncology 11(4):346–355CrossRefPubMed
17.
go back to reference Brennan ME, Spillane AJ (2007) The breast physician: an example of specialisation in general practice. Med J Aust 187(2):111PubMed Brennan ME, Spillane AJ (2007) The breast physician: an example of specialisation in general practice. Med J Aust 187(2):111PubMed
18.
go back to reference Lewis RA, Neal RD, Williams NH et al (2009) Follow-up of cancer in primary care versus secondary care: systematic review. Br J Gen Pract 59(564):234–247CrossRef Lewis RA, Neal RD, Williams NH et al (2009) Follow-up of cancer in primary care versus secondary care: systematic review. Br J Gen Pract 59(564):234–247CrossRef
19.
go back to reference Donnelly P, Hiller L, Bathers S et al (2007) Questioning specialists’ attitudes to breast cancer follow-up in primary care. Ann Oncol 18(9):1467–1476CrossRefPubMed Donnelly P, Hiller L, Bathers S et al (2007) Questioning specialists’ attitudes to breast cancer follow-up in primary care. Ann Oncol 18(9):1467–1476CrossRefPubMed
20.
go back to reference Hewitt M, Greenfield S, Stovall E (2005) From cancer patient to cancer survivor: lost in transition. The National Academies Press, Washington D.C Hewitt M, Greenfield S, Stovall E (2005) From cancer patient to cancer survivor: lost in transition. The National Academies Press, Washington D.C
21.
go back to reference McCabe MS, Bhatia S, Oeffinger KC et al (2013) American society of clinical oncology statement: achieving high-quality cancer survivorship care. J Clin Oncol 31(5):631–640CrossRefPubMed McCabe MS, Bhatia S, Oeffinger KC et al (2013) American society of clinical oncology statement: achieving high-quality cancer survivorship care. J Clin Oncol 31(5):631–640CrossRefPubMed
22.
go back to reference Naidoo J, Hayes E, Teo M et al (2013) An Irish breast cancer survivorship study: are we meeting our patients’ needs? IMJ 106(9):262–266PubMed Naidoo J, Hayes E, Teo M et al (2013) An Irish breast cancer survivorship study: are we meeting our patients’ needs? IMJ 106(9):262–266PubMed
23.
go back to reference Montgomery DA, Krupa K, Wilson C et al (2008) Patients’ expectations for follow-up in breast cancer—A preliminary, questionnaire-based study. Breast 17(4):347–352CrossRefPubMed Montgomery DA, Krupa K, Wilson C et al (2008) Patients’ expectations for follow-up in breast cancer—A preliminary, questionnaire-based study. Breast 17(4):347–352CrossRefPubMed
24.
go back to reference Andersen R, Bowen D, Morea J et al (2009) Involvement in decision-making and breast cancer survivor quality of life. Health Psychol 28(1):29–37CrossRefPubMed Andersen R, Bowen D, Morea J et al (2009) Involvement in decision-making and breast cancer survivor quality of life. Health Psychol 28(1):29–37CrossRefPubMed
25.
go back to reference Grunfeld E, Mant D, Vessey MP et al (1995) Specialist and general practice views on routine follow-up of breast cancer patients in general practice. Fam Pract 12(1):60–65CrossRefPubMed Grunfeld E, Mant D, Vessey MP et al (1995) Specialist and general practice views on routine follow-up of breast cancer patients in general practice. Fam Pract 12(1):60–65CrossRefPubMed
Metadata
Title
Long-term follow-up of women with breast cancer: rationale for policy change
Authors
T. McCarthy
L. Mullen
H. Murphy
D. Carey
M. Laffoy
Publication date
01-12-2015
Publisher
Springer London
Published in
Irish Journal of Medical Science (1971 -) / Issue 4/2015
Print ISSN: 0021-1265
Electronic ISSN: 1863-4362
DOI
https://doi.org/10.1007/s11845-014-1202-4

Other articles of this Issue 4/2015

Irish Journal of Medical Science (1971 -) 4/2015 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine